» Articles » PMID: 26221

Chronic Cutaneous Graft-versus-host Disease in Man

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1978 Jun 1
PMID 26221
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

This clinicopathologic study of patients with chronic graft-versus-host disease (GVHD) after allogeneic marrow transplantation emphasizes the most prominent feature of the syndrome, the cutaneous aspects, and describes the ophthalmic-oral sicca syndrome with sialoadenitis and the neurologic findings. Chronic cutaneous GVHD affected 19 of 92 recipients surviving 150 days or more. In 6 patients chronic GVHD presented as a continuation of acute GVHD; in 8 it occurred after the resolution of acute GVHD; and in 5 it arose without preceding acute GVHD, ie, de novo late onset. Two cutaneous types were distinguished. The generalized type affected 16 patients and ran a progressive course resulting in late complications of poikiloderma, diffuse dermal and subcutaneous fibrosis, and contractures. Microscopically, it resembled generalized morphea and lupus erythermatosus hypertrophicus et profundus. The local type affected 3 patients with a more variable picture of poikiloderma, dermal sclerosis, and contractures. Microscopically, it resembled lupus of erythematosus profundus and scleroderma. Guidelines for defining and subclassifying chronic cutaneous GVHD are proposed.

Citing Articles

Immunopathogenic mechanisms and modulatory approaches to graft-versus-host disease prevention in acute myeloid leukaemia.

Pang Y, Holtzman N Best Pract Res Clin Haematol. 2023; 36(2):101475.

PMID: 37353287 PMC: 10291443. DOI: 10.1016/j.beha.2023.101475.


Association Between Candidemia and Noninfectious Interstitial Pneumonia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group.

Kimura S, Akahoshi Y, Shiratori S, Okinaka K, Harada K, Uchida N Open Forum Infect Dis. 2023; 10(4):ofad163.

PMID: 37089776 PMC: 10120431. DOI: 10.1093/ofid/ofad163.


Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Kimura S, Shimizu H, Miyazaki T, Sakurai M, Tanoue S, Kayamori K Bone Marrow Transplant. 2022; 58(4):452-455.

PMID: 36572728 DOI: 10.1038/s41409-022-01901-5.


Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II-IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications....

Kimura S, Tamaki M, Okinaka K, Seo S, Uchida N, Igarashi A Ann Hematol. 2021; 100(12):3029-3038.

PMID: 34490500 DOI: 10.1007/s00277-021-04660-3.


Unraveling the Mechanisms of Cutaneous Graft-Versus-Host Disease.

Santos E Sousa P, Bennett C, Chakraverty R Front Immunol. 2018; 9:963.

PMID: 29770141 PMC: 5940745. DOI: 10.3389/fimmu.2018.00963.


References
1.
Spielvogel R, Ullman S, GOLTZ R . Skin changes in graft-vs-host disease. South Med J. 1976; 69(10):1277-81. DOI: 10.1097/00007611-197610000-00009. View

2.
FLEISCHMAJER R, Perlish J, Shaw K, Pirozzi D . Skin capillary changes in early systemic scleroderma. Electron microscopy and "in vitro" autoradiography with tritiated thymidine. Arch Dermatol. 1976; 112(11):1553-7. View

3.
Campbell P, LeRoy E . Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum. 1975; 4(4):351-68. DOI: 10.1016/0049-0172(75)90017-7. View

4.
Storb R, Thomas E, Weiden P, Buckner C, Clift R, Fefer A . Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle. Blood. 1976; 48(6):817-41. View

5.
de Vries M, CROUCH B, van PUTTEN L, van BEKKUM D . Pathologic changes in irradiated monkeys treated with bone marrow. J Natl Cancer Inst. 1961; 27:67-97. View